What is the latest price of Ustekinumab in 2024?

Ustekinumab (Ustekinumab) is used to treat adults and children 6 years or older who may benefit from medications or phototherapy (a treatment that involves exposing the skin to ultraviolet light) Moderate to severe plaque psoriasis (a skin disease that causes red, scaly patches on some parts of the body) in children; it is also used alone or in combination with methotrexate to treat psoriatic arthritis (a disease that causes pain and swelling in the joints and scaly skin) in adults.

Ustekinumab is also used to treat Crohn's disease in adults (a disease in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss and fever). Ustekinumab is also used to treat ulcerative colitis (a disease that causes swelling and ulcers in the lining of the colon [large intestine] and rectum) in adults. Ustekinumab belongs to a class of drugs called monoclonal antibodies. It works by stopping the activity of certain cells in the body that cause symptoms of plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.

The generic drug Ustekinumab has been launched in China and is included in the medical insurance, and is only reimbursed for patients who meet the indications. The price of the 130mg/26ml intravenous injection preparation may be more than 5,000 yuan per box, and the price of the 90mg: 1.0ml*1 subcutaneous injection preparation may be more than 8,000 yuan per box. The price of the 130mg/26ml intravenous injection preparation of Ustekinumab sold overseas may be more than 2,000 US dollars per box, and the price of 45mg: 0.5ml*1 subcutaneous injection preparation per box may be more than 10,000 US dollars. There are currently no generic versions of ustekinumab produced in other overseas countries.